Nifty 18210.95 (-0.31%)
Sensex 61143.33 (-0.34%)
Nifty Bank 40874.35 (-0.88%)
Nifty IT 35503.9 (0.97%)
Nifty Financial Services 19504.75 (-0.74%)
Adani Ports 745.85 (-0.54%)
Asian Paints 3094.65 (4.20%)
Axis Bank 787.50 (-6.46%)
B P C L 427.70 (-0.78%)
Bajaj Auto 3776.50 (-0.40%)
Bajaj Finance 7482.15 (-4.75%)
Bajaj Finserv 18012.00 (-1.86%)
Bharti Airtel 702.35 (0.88%)
Britannia Inds. 3697.85 (0.14%)
Cipla 922.50 (1.65%)
Coal India 173.60 (-0.83%)
Divis Lab. 5149.35 (2.60%)
Dr Reddys Labs 4662.70 (-0.08%)
Eicher Motors 2583.90 (-0.25%)
Grasim Inds 1728.40 (-0.63%)
H D F C 2915.00 (0.12%)
HCL Technologies 1177.15 (0.89%)
HDFC Bank 1642.80 (-0.60%)
HDFC Life Insur. 693.85 (0.55%)
Hero Motocorp 2690.15 (-0.38%)
Hind. Unilever 2396.60 (-1.65%)
Hindalco Inds. 479.85 (-1.28%)
I O C L 130.80 (-0.53%)
ICICI Bank 835.00 (0.68%)
IndusInd Bank 1142.55 (-1.07%)
Infosys 1728.95 (1.48%)
ITC 238.45 (0.74%)
JSW Steel 684.90 (-1.36%)
Kotak Mah. Bank 2188.25 (-1.03%)
Larsen & Toubro 1784.55 (-0.65%)
M & M 886.80 (-0.87%)
Maruti Suzuki 7356.25 (0.81%)
Nestle India 19004.60 (-1.11%)
NTPC 141.30 (-1.33%)
O N G C 157.90 (-3.19%)
Power Grid Corpn 190.25 (-0.08%)
Reliance Industr 2627.40 (-1.26%)
SBI Life Insuran 1186.00 (1.19%)
Shree Cement 28107.75 (1.19%)
St Bk of India 519.15 (1.29%)
Sun Pharma.Inds. 825.10 (1.43%)
Tata Consumer 818.75 (1.22%)
Tata Motors 497.90 (-2.11%)
Tata Steel 1326.15 (-1.30%)
TCS 3489.75 (0.21%)
Tech Mahindra 1567.85 (0.29%)
Titan Company 2460.10 (0.22%)
UltraTech Cem. 7354.20 (1.17%)
UPL 741.50 (3.96%)
Wipro 671.10 (0.44%)

Krsnaa Diagnostics IPO Subscription Day-1

Krsnaa Diagnostics IPO Subscription Day-1
IPO
04/08/2021

The Rs.1,213.33 crore IPO of Krsnaa Diagnostics, consisting of Rs.400 crore fresh issue and Rs.813.33 crore OFS, has gradually built response on Day-1 of the IPO. As per the combined bid details put out by the BSE, Krsnaa Diagnostics IPO was subscribed 1.98X overall, with bulk of the demand coming from the retail segment. The issue has 2 more days to go.

As of the close of 04 August, out of the 71.12 lakh shares on offer in the IPO, Krsnaa Diagnostics saw applications for 140.64 lakh shares. This implies an overall subscription of 1.98X. The granular break-up of subscriptions were tilted substantially in favour of retail investors but HNI and QIB bids would typically come in on the last day. 

 

Krsnaa Diagnostics IPO Subscription Day 1

 

Category

Subscription Status
Qualified Institutional (QIB) 0.48 Times
Non-Institutional (NII) 0.15 Times
Retail Individual 9.59 Times
Employee 0.12 Times
Total 1.98  Times

 

QIB Portion

The QIB portion remained tepid at the end of Day-1. On 03 Aug, Krsnaa Diagnostics did an anchor placement of Rs.537 crore to QIB investors like Kuber, Volrado, HSBC, SocGen, Elara, Nomura etc. QIB portion is just subscribed 0.48X, at the end of the first day of bidding.

HNI Portion

The HNI portion got subscribed 0.15X (getting applications for 2.81 lakh shares against the quota of 18.76 lakh shares). Of course, funded applications and corporate applications will come in on the last day. The real big story was the retail portion, which is already subscribed 9.55 times at the end of Day-1, showing strong retail appetite.

Retail Portion

Among retail investors; out of the 12.51 lakh shares on offer, valid bids were received for 119.50 lakh shares, of which bids for 97.11 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.933-Rs.954) and will close for subscription on Friday, 06 August. Krsnaa has limited retail quota to 10% while institutions have 75% allocation.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
There is some issue, try later
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Windlas Biotech IPO Subscription Day-1

Windlas Biotech IPO Subscription Day-1
IPO
04/08/2021

The Rs.401.54 crore IPO of Windlas Biotech, consisting of Rs.165 crore fresh issue and Rs.236.54 crore OFS, has gradually built on the response from retail investors on Day-1. As per the combined bid details put out by the BSE, Windlas Biotech IPO was subscribed 3.17X overall, with bulk of the demand coming from the retail segment followed by the HNI segment.

As of close of 04 August, out of the 61.36 lakh shares on offer in the IPO, Windlas Biotech saw applications for 193.37 lakh shares. This implies an overall subscription of 3.15X. The granular break-up of subscriptions were tilted in favour of retail investors but HNI portion and QIB bids would typically come in on the last day.

Windlas Biotech IPO Subscription Day 1

Category Subscription Status
Qualified Institutional (QIB) 0.00 Times
Non-Institutional (NII) 0.34 Times
Retail Individual 6.15 Times
Total 3.17 Times

 

QIB Portion

The QIB portion did not open its account at the end of Day-1. On 03 August, Windlas Biotech did an anchor placement of Rs.120.46 crore to 22 QIB investors like Macquarie, Optimix, Invesco, Kubera, Elara, Avendus etc. QIB portion did not see any action on Day-1.

HNI Portion

The HNI portion got subscribed 0.34X (getting applications for 4.435 lakh shares against the quota of 13.238 lakh shares). Of course, funded applications and corporate applications, will come in on the last day.

Retail Portion

The real story was the retail portion, which is already subscribed 6.15 times at the end of Day-1, showing strong retail appetite. Among retail investors; out of the 30.89 lakh shares on offer, valid bids were received for 188.94 lakh shares, of which bids for 147.96 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.448-Rs.460) and will close for subscription on Friday, 06 August.
 

Next Article

Windlas Biotech IPO Subscription Day-2

Windlas Biotech IPO Subscription Day-2
IPO
05/08/2021

The Rs.401.54 crore IPO of Windlas Biotech, consisting of Rs.165 crore fresh issue and Rs.236.54 crore OFS, had been fully subscribed on Day-1 itself. As per the combined bid details put out by the BSE, Windlas Biotech IPO was subscribed 7.06X overall, with bulk of the demand coming from the retail segment followed by HNI segment. 

As of close of 05 August, out of the 61.36 lakh shares on offer in the IPO, Windlas Biotech saw applications for 429.22 lakh shares. This implies an overall subscription of 7.06X. The granular break-up of subscriptions were tilted in favour of retail investors but HNI and QIB bids typically come in on the last day.

 

Windlas Biotech IPO Subscription Status

Category Subscription Status
Qualified Institutional (QIB) 0.04 Times
Non-Institutional (NII) 1.12 Times
Retail Individual 13.52 Times
Total 7.06 Times

 

QIB Portion

The QIB subscription remained marginal at the end of Day-2. On 03 August, Windlas Biotech did an anchor placement of Rs.120.46 crore to 22 QIB investors including Macquarie, Optimix, Invesco, Kubera, Elara, Avendus etc. The QIB portion (net of anchor allocation) has a quota of 17.24 lakh shares of which it has got bids for just 0.70 lakh shares, implying a subscription ratio of 0.04X for QIBs at the end of Day-2.

HNI Portion

The HNI portion got subscribed 1.12X (getting applications for 14.70 lakh shares against the quota of 13.24 lakh shares). Bulk of the funded applications and corporate applications, come in on the last day. 

Retail Individuals

The retail portion is subscribed 13.52X at the end of Day-2, showing strong retail appetite. For retail investors; out of the 30.89 lakh shares on offer, valid bids were received for 413.82 lakh shares, of which bids for 319.12 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.448-Rs.460) and will close for subscription on 06 August.

Next Article

Exxaro Tiles IPO Subscription Day-2

Exxaro Tiles IPO Subscription Day-2
IPO
05/08/2021

The Rs.161.09 crore IPO of Exxaro Tiles, consisting of Rs.134.23 crore fresh issue and Rs26.86 crore OFS, had been fully subscribed at the end of Day-1 itself; thanks to strong response from retail investors. As per the combined bid details put out by the BSE at the end of Day-2 of the issue, Exxaro Tiles IPO was subscribed 10.40X overall, with bulk of the demand coming from the retail segment. The issue still has 1 more day to go.

As of close of 05 Aug, out of the 114.51 lakh shares on offer in the IPO, Exxaro Tiles saw applications for 1,178.81 lakh shares. This implies an overall subscription of 10.40X. The granular break-up of subscriptions were tilted in favour of retail investors but QIB and HNI bids typically come in on the last day
 

 

Exxaro Tiles IPO Subscription Status

Category

Subscription Status
Qualified Institutional (QIB) 1.66Times
Non-Institutional (NII) 0.97 Times
Retail Individual 21.29 Times
Employee 1.56 Times
Total 10.40  Times

 

QIB Portion

The QIB portion got more than full subscription of its quota at the end of Day-2. On 03 Aug, Exxaro Tiles did an anchor placement worth Rs.26.86 crore. QIB portion, net of anchor allocation, was subscribed 1.66X (getting applications for 21.66 lakh shares against the available quota of 13.16 lakh shares) at the end of Day-2.

HNI Portion

The HNI portion got subscribed 0.97X (getting applications for 42.80 lakh shares against the quota of 46.04 lakh shares). Funded applications and corporate applications, normally come in on the last day and the picture tends to change quite dramatically by then. 

Retail Individuals

The retail portion is already subscribed 21.29X at the end of Day-2, showing strong retail appetite. Out of the 52.62 lakh shares on offer, valid bids were received for 1,110.17 lakh shares, of which bids for 879.27 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.118-Rs.120) and will close for subscription on Friday, 06 August.
 

Next Article

Krsnaa Diagnostics IPO Subscription Day-2

Krsnaa Diagnostics IPO Subscription Day-2
IPO
05/08/2021

The Rs.1,213.33 crore IPO of Krsnaa Diagnostics, consisting of Rs.400 crore fresh issue and Rs.813.33 crore OFS, had been fully subscribed on Day-1 itself. As per the combined bid details put out by the BSE, Krsnaa Diagnostics IPO was subscribed 5.42X overall at the end of Day-2 of the issue, with bulk of the demand coming from retail segment.

As of close of 05 August, out of the 71.12 lakh shares on offer in the IPO, Krsnaa Diagnostics saw applications for 380.34 lakh shares. This implies an overall subscription of 5.42X. The granular break-up of subscriptions were tilted heavily in favour of retail investors.

 

Krsnaa Diagnostics IPO Subscription Status

Category

Subscription Status
Qualified Institutional (QIB) 0.50 Times
Non-Institutional (NII) 4.76 Times
Retail Individual 22.09 Times
Employee 0.52 Times
Total 5.42  Times

 

QIB Portion

The QIB portion remained tepid at the end of Day-2. On 03 Aug, Krsnaa Diagnostics did an anchor placement of Rs.537 crore to QIB investors like Kuber, Volrado, HSBC, SocGen, Elara, Nomura etc. QIB portion is just subscribed 0.50X (getting applications for 18.82 lakh shares against the net quota of 37.53 lakh shares), at the end of the Day-2. Normally bulk of the QIB applications come in on the last day.

HNI Portion

The HNI portion saw good subscription at 4.76X (getting applications for 88.33 lakh shares against the quota of 18.76 lakh shares). This number could see a sharp increase once the funded and corporate applications come in on the last day.

Retail Individuals

The retail portion is already subscribed 22.09 times at the end of Day-2, showing strong retail appetite. Among retail investors; out of the 12.51 lakh shares on offer, valid bids were received for 271.98 lakh shares, of which bids for 219.85 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.933-Rs.954) and will close for subscription on Friday, 06 August. Krsnaa has limited retail quota to 10% while institutions have 75% allocation.

Next Article

Devyani International IPO Subscription Day-2

Devyani International IPO Subscription Day-2
IPO
05/08/2021

The Rs.1,838 crore IPO of Devyani International, consisting of Rs.440 crore fresh issue and Rs.1,398 crore OFS, built on the response from retail investors on Day-2. As per the combined bid details put out by the BSE, Devyani International IPO was subscribed 6.73X overall, with bulk of the demand coming from the retail segment followed by HNI segment. The issue closes for subscription on Friday, 06 August.

As of close of 05 August, out of the 1,125.70 lakh shares on offer, Devyani International saw bids for 7,440.74 lakh shares. This implies an overall subscription of 6.73X. The granular break-up of subscriptions were tilted in favour of retail investors and, to an extent, HNIs too.
 

Devyani International IPO Subscription Status

Category

Subscription Status
Qualified Institutional (QIB) 1.32 Times
Non-Institutional (NII) 6.68 Times
Retail Individual 23.16 Times
Employee 3.12 Times
Total 6.73  Times

 

QIB Portion

The QIB portion saw 1.32X subscription with demand for 805.28 lakh shares against 611.02 shares available; net of anchor placement. On 03 August, Devyani International did anchor placement of Rs.824.87 crore to QIB investors like ADIA, Fidelity, Goldman Sachs, Government of Singapore, MAS, Kuwait Investment Authority etc. 

HNI Portion

The HNI portion got subscribed 6.68X (getting applications for 1,945.36 lakh shares against the quota of 305.51 lakh shares). Funded applications and corporate applications, come in on last day, but it promises to be a solid subscription at the end of Day-3. 

Retail Individuals

The retail portion got subscribed 23.16X times at the end of Day-2, showing strong retail appetite. Among retail investors; out of the 203.67 lakh shares on offer, valid bids were received for 4,673.03 lakh shares, of which bids for 3,672.96 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.86-Rs.90) and has allocated a quota of 10% for retail and 75% for QIBs.